Bioterrorism
This presentation is the property of its rightful owner.
Sponsored Links
1 / 41

Bioterrorism: PowerPoint PPT Presentation


  • 67 Views
  • Uploaded on
  • Presentation posted in: General

Bioterrorism:. Are Physician Assistants Prepared to Diagnose and Treat?. Mark Bostic Spring 2006 PAS 646. Objectives. 1) Talk about PA preparedness 2) Talk about bioterroristic diseases. What is bioterrorism?.

Download Presentation

Bioterrorism:

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Bioterrorism

Bioterrorism:

Are Physician Assistants Prepared to Diagnose and Treat?

Mark Bostic

Spring 2006

PAS 646


Objectives

Objectives

  • 1) Talk about PA preparedness

  • 2) Talk about bioterroristic diseases


What is bioterrorism

What is bioterrorism?

  • Form of terrorism in which biological agents are used to inflict harm and/or fear upon a population.

http://www.fbi.gov/anthrax/images.htm#1


Physician assistant training

Physician Assistant Training

  • Medical school model

  • Consistent with physician training

  • Bioterrorism?


Bioterrorism training

Bioterrorism Training

  • Physician Assistant Programs’ Websites

    • No training specified

  • Accreditation Review Commission on Physician Assistant Programs (ARC-PA)

    • No training mandated

  • Liaison Committee on Medical Education (LCME)

    • No training mandated


Physician assistant preparedness

Physician Assistant Preparedness

  • Studies lacking for PA’s

  • Physician preparedness

    • HHS Agency for Healthcare Research and Quality (AHRQ) survey indicates physicians unprepared

      • n=614 physicians, 18% trained, 93% expressed interest

    • Johns Hopkins University study indicates physicians unprepared

      • n=2407 physicians, pretest 46.8%, posttest 79%

      • Chickenpox vs. smallpox, botulism vs. Guillain-Barre


Cdc top six bioterroristic agents

CDC top six bioterroristic agents

  • Anthrax

  • Smallpox

  • Plague

  • Viral hemorrhagic fevers

  • Botulism

  • Tularemia


Anthrax

Anthrax

  • Bacillus anthracis

    • Spore-forming bacterium

  • Livestock, meat products, wool sorters

  • Inhalational, cutaneous, gastrointestinal

  • Often misdiagnosed as influenza


Inhalational anthrax

Inhalational anthrax

  • Most deadly

  • Incubation period

  • Replication and toxin release

  • Phase I: nonspecific constitutional symptoms

    • Mild fever, malaise, myalgia, nonproductive cough, emesis, chest/abdominal pain

  • Phase II: more severe

    • Higher fever, chest/neck edema, mediastinal widening, dyspnea, cyanosis, meningoencephalitis, shock


Diagnosis inhalational anthrax

Diagnosis: inhalational anthrax

  • Chest x-ray and chest CT

    • Mediastinal widening, pleural effusion, consolidation

  • Blood smear and gram stain/culture

    • Large bacilli

    • Left shift

  • Cerebrospinal Fluid

    • Purulence, decr. glucose, incr. protein, elevated pressure, blood


Inhalational anthrax1

Inhalational anthrax

www.cdc.gov


Cutaneous anthrax

Cutaneous anthrax

  • Most prevalent form of infection

  • Skin barrier must be compromised

  • Replication and toxin release

    • May take up to 14 days


Diagnosis cutaneous anthrax

Diagnosis: cutaneous anthrax

  • 1) pruritic papule or pustule surrounded by smaller vesicles

  • 2) mild fever and malaise

  • 3) papule enlarges to a circular lesion surrounded by edema

    • Ruptures and necroses

    • Characteristic “Black Eschar”


Cutaneous anthrax1

Cutaneous anthrax

www.cdc.gov


Treatment anthrax

Treatment: anthrax

  • Combination of:

    • Ciprofloxacin (Cipro ®)

    • Doxycycline (Vibramycin ®)

  • Combination varies depending upon:

    • Adult, child, immunocompromised

  • Amoxicillin for pregnant females


Smallpox variola

Smallpox (Variola)

  • DNA virus

  • Transmitted in droplet form

  • Respiratory tract mucosa

  • 12-14 day incubation period

  • Often misdiagnosed as varicella


Diagnosis smallpox

Diagnosis: smallpox

  • Rapid onset of nonspecific sx’s

    • Fever, HA, malaise, chills, myalgia, anorexia, N/V, diarrhea, abdominal pain, delirium, convulsions

  • Papules surrounded by rash a few days later

  • Centrifugal distribution

  • Papules  pustules  crusted lesion

  • Simultaneous staging of lesions

  • Not “dewdrops on a rose petal”


Smallpox

Smallpox

www.cdc.gov


Treatment smallpox

Treatment: smallpox

  • No cure

  • Tx is supportive

  • Vaccination available = Vaccinia


Plague

Plague

  • Yersinia pestis

    • Gram negative, pleomorphic coccobacillus

    • Infects by fleas carried by rodents

  • Bubonic, septicemic, pneumonic


Diagnosis bubonic and pneumonic plague

Diagnosis: bubonic and pneumonic plague

  • Onset of nonspecific sx’s in 2 to 6 days

    • Fever, chills, weakness, malaise, myalgia, lethargy

    •  chest pain, dyspnea, watery/bloody expectorated sputum

    • Tender buboes (swollen lymph nodes)

    • 2 to 4 days later, lung exhibits necrosis, infiltration, hemorrhaging, effusion, abscesses

  • Chest x-ray

  • Hypotension, respiratory distress, pulmonary edema = death in 24 hours


Plague1

Plague

www.cdc.gov


Diagnosis septicemic plague

Diagnosis: septicemic plague

  • Fever, chills, prostration, N/V, abdominal pain

  • Purpura and DIC  hypotension, shock, and death

  • Blood cultures (all types of plague)

    • Prior to tx with antibiotics

  • Gram stain & culture (all types of plague)

    • Prior to tx with antibiotics

  • Sputum sample


Treatment plague

Treatment: plague

  • Streptomycin (1st line)

  • Gentamicin (2nd line)

  • Tetracylines such as chloramphenicol


Viral hemorrhagic fevers

Viral hemorrhagic fevers

  • RNA viruses:

    • Arenavirus, bunyavirus, filovirus, flavivirus

  • Infection via vectors:

    • Mosquitoes, ticks, cats, rabbits, people

  • History should include travel to tropical regions


Diagnosis vhf

Diagnosis: VHF

  • Onset of nonspecific symptoms:

    • Fever, HA, myalgia/arthralgia, N/V, diarrhea

    • Possible bradycardia, tachycardia, liver necrosis, delirium, confusion, coma

  • Hallmark: generalized systemic coagulopathy with profuse bleeding

    • Petechiae, ecchymoses, epistaxis, hematemesis

    • Bleeding from gingiva, vagina, any puncture sites

  • Definitive: immunoglobulin Antibody to specific virus


Viral hemorrhagic fevers1

Viral hemorrhagic fevers

http://www.gata.edu.tr/dahilibilimler/infeksiyon/resimler/VIRAL_HEMORRHAGIC_FEVER/__VIRAL_HEMORRHAGIC_FEVERS_2.JPG


Treatment vhf

Treatment: VHF

  • No FDA approved drugs

  • Ribavirin may be effective

  • Supportive treatment of shock:

    • Hydration, blood transfusions, etc.


Botulism

Botulism

  • Spore-forming anaerobic bacterium Clostridium botulinum

  • Toxin is most lethal of all toxins

    • 100,000x sarin gas

    • 15,000x nerve gas

  • Iraq: enough to kill every human 3 times

  • Bacterium or toxin may be aerosolized, placed in food supplies

  • Blocks ACh release


Diagnosis botulism

Diagnosis: botulism

  • Descending paralysis

  • Ptosis, diplopia, blurred vision, and dilated, sluggish pupils

  • Difficulty speaking, chewing, swallowing

  • Paralytic asphyxiation or flaccid airway collapse

  • Culture serum, stool, gastric contents, suspected food


Treatment botulism cont

Treatment: botulism (cont.)

  • Equine botulinum antiserum

  • Antibiotic therapy experimental

    • Metronidazole

    • PCN

  • Supportive: ventilation and tube feeding


Tularemia

Tularemia

  • Nonmotile, aerobic gram negative coccobacillus Francisella tularensis

    • 2 subspecies: biovar tularensis & biovar palaeartica

  • Bite of tick, mosquito, handling infected carcass

  • Aerosolization possible

  • Incubates, then moves to LN and multiplies

  • Pathology at all sites where bacillus spreads


Diagnosis tularemia

Diagnosis: tularemia

  • Site of inoculation: papule-pustule-ulcer pattern

  • Eye: ulceration of conjunctiva with LAD

  • Oral: tonsillitis or pharyngitis with cervical LAD

  • Lungs: bronchiolitis, pneumonitis, pleuropneumonitis with LAD

  • Fever, abdominal pain, diarrhea, emesis

  • IF, GS&C


Tularemia1

Tularemia

http://www.logicalimages.com/resourcesBTAgentsTularemia.htm

http://phil.cdc.gov/Phil/details.asp


Treatment tularemia

Treatment: tularemia

  • Ciprofloxacin or doxycycline (early)

  • Streptomycin or gentamicin (late)

  • No vaccine


Reporting

Reporting

  • Written plan in every health care facility

  • Notify local health care officer for suspected or confirmed cases


Conclusion

Conclusion

  • Data suggest that physicians are unprepared to diagnose and manage diseases of a bioterroristic cause.

  • Studies need to be performed to determine whether or not PA’s are prepared.


Bioterrorism 3a

  • Thank you for your attention!


References

References

  • ARC-PA (2005). “Accreditation standards for physician assistant education.” Section B(1-7): 11-13.

  • CDC (2005). “Agents, diseases, and other threats.” Cited on World Wide Web 1 December 2005 at http://www.bt.cdc.gov/agent/.

  • Cosgrove, S. E., T. M. Perl, X. Song, S. D. Sisson (2005). “Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.” Archives of Internal Medicine 165(17): 2002-2006.

  • Endy, T. P., S. J. Thomas, J. V. Lawler (2005). “History of U.S. Military Contributions To The Study of Viral Hemorragic Fevers.” Military Medicine 170(4): 77-91.

  • Goad, J. A., J. Nguyen (2003). “Hemorrhagic Fever Viruses.” Top Emerg Med 25(1): 66-72.

  • Hickner, J., F. M. Chen (2002). “Survey on Eve of Anthrax Attacks Showed Need for Bioterrorism Training.” Press release 5 September 2002. Agency for Healthcare Research and Quality, Rockville, MD. Cited on World Wide Web on 22 December 2005 at http://www.ahrq.gov/news/press/pr2002/anthraxpr.htm

  • Karwa, M. (2005). “Bioterrorism: Preparing for the impossible or the improbable.” Critical Care Medicine 33(1 Suppl): S75-95.


References1

References

  • LCME (2004). “Functions and structure of a medical school.” Section II(A): 2.

  • Leger, M. M., R. McNellis, R. Davis, L. Larson, R. Muma, T. Quigley, S. Toth (2001). “Biological and chemical terrorism: Are we clinicians ready?” American academy of physician assistants. Cited on world wide web 3 January 2005 at http://www.aapa.org/

  • clinissues/BTtext.htm.

  • Lohenry, K. (2004). “Anthrax exposure – stay alert, act swiftly” Journal of the American Academy of Physician Assistants 17(8): 29-33.

  • NPR online, (2005). “History of Biological Warfare.” Cited on World Wide Web 21 November 2005 at http://www.npr.org/news/specials/response/anthrax/features/2001/

  • oct/011018.bioterrorism.history.html.

  • O’Brien, K., M. Higdon, J. Halverson (2003). “Recognition and Management of Bioterrorism Infections.” American Family Physician 67(9): 1927-34.

  • Straight, T. M., A. A. Lazarus, C. F. Decker (2002). “Defending Against Viruses in Biowarfare.” Postgraduate Medicine 112(2): 75-80.


References2

References

  • Varkey, P., G. Poland, F. Cockerill, T. Smith, P. Hagen (2002). “Confronting Bioterrorism: Physicians on the Front Line.” Mayo Clinic Proceedings 77(7): 661-72.

  • United States Department of Health and Human Services (2002). “HHS announces $1.1 billion in funding to states for bioterrorism preparedness.” HHS press release 31 January 2002. Cited on World Wide Web 30 December 2005 at http://www.hhs.gov/news/press/

  • 2002pres/20020131b.html.


  • Login